BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31892524)

  • 1. The Challenge of Classifying Metastatic Cell Properties by Molecular Profiling Exemplified with Cutaneous Melanoma Cells and Their Cerebral Metastasis from Patient Derived Mouse Xenografts.
    Neuditschko B; Janker L; Niederstaetter L; Brunmair J; Krivanek K; Izraely S; Sagi-Assif O; Meshel T; Keppler BK; Del Favero G; Witz IP; Gerner C
    Mol Cell Proteomics; 2020 Mar; 19(3):478-489. PubMed ID: 31892524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metastatic microenvironment: Brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells.
    Klein A; Sagi-Assif O; Izraely S; Meshel T; Pasmanik-Chor M; Nahmias C; Couraud PO; Erez N; Hoon DS; Witz IP
    Int J Cancer; 2012 Dec; 131(11):2509-18. PubMed ID: 22447293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis.
    Izraely S; Sagi-Assif O; Klein A; Meshel T; Tsarfaty G; Pasmanik-Chor M; Nahmias C; Couraud PO; Ateh E; Bryant JL; Hoon DS; Witz IP
    Int J Cancer; 2012 Sep; 131(5):1071-82. PubMed ID: 22025079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasis.
    Izraely S; Sagi-Assif O; Klein A; Meshel T; Ben-Menachem S; Zaritsky A; Ehrlich M; Prieto VG; Bar-Eli M; Pirker C; Berger W; Nahmias C; Couraud PO; Hoon DS; Witz IP
    Int J Cancer; 2015 Mar; 136(6):1296-307. PubMed ID: 25046141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic Profiling of Archived Tissue of Primary Melanoma Identifies Proteins Associated with Metastasis.
    Shapanis A; Lai C; Sommerlad M; Parkinson E; Healy E; Skipp P
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.
    Schadendorf D; Fichtner I; Makki A; Alijagic S; Küpper M; Mrowietz U; Henz BM
    Br J Cancer; 1996 Jul; 74(2):194-9. PubMed ID: 8688321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.
    Li L; Zhang S; Li H; Chou H
    BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metastatic microenvironment: Melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cells.
    Izraely S; Ben-Menachem S; Sagi-Assif O; Telerman A; Zubrilov I; Ashkenazi O; Meshel T; Maman S; Orozco JIJ; Salomon MP; Marzese DM; Pasmanik-Chor M; Pikarski E; Ehrlich M; Hoon DSB; Witz IP
    Int J Cancer; 2019 Feb; 144(4):802-817. PubMed ID: 29992556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The melanoma brain metastatic microenvironment: aldolase C partakes in shaping the malignant phenotype of melanoma cells - a case of inter-tumor heterogeneity.
    Izraely S; Ben-Menachem S; Sagi-Assif O; Meshel T; Malka S; Telerman A; Bustos MA; Ramos RI; Pasmanik-Chor M; Hoon DSB; Witz IP
    Mol Oncol; 2021 May; 15(5):1376-1390. PubMed ID: 33274599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of Tn-bearing glycoproteins from different stages of melanoma cells reveals new biomarkers.
    Hoja-Łukowicz D; Szwed S; Laidler P; Lityńska A
    Biochimie; 2018 Aug; 151():14-26. PubMed ID: 29802864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic expression of nm23 predicts the potential for cerebral metastasis in patients with primary cutaneous melanoma.
    Sarris M; Scolyer RA; Konopka M; Thompson JF; Harper CG; Lee CS
    Melanoma Res; 2004 Feb; 14(1):23-7. PubMed ID: 15091190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aquaporin-1 Protein Expression of the Primary Tumor May Predict Cerebral Progression of Cutaneous Melanoma.
    Imrédi E; Liszkay G; Kenessey I; Plotár V; Gödény M; Tóth B; Fedorcsák I; Tímár J
    Pathol Oncol Res; 2020 Jan; 26(1):405-410. PubMed ID: 30378011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IMP3 Immunohistochemical Expression Is Related with Progression and Metastases in Xenografted and Cutaneous Melanomas.
    Martin-Morales N; Padial-Molina M; Tovar I; De Araujo Farias V; Hernández-Cortés P; Ramirez-Moreno E; Caba-Molina M; Davis J; Carrero Castaño A; Ruiz de Almodovar JM; Galindo-Moreno P; Oliver-Pozo J; O'Valle Ravassa FJ
    Pathobiology; 2024; 91(2):132-143. PubMed ID: 37797584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
    Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
    Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two human melanoma cell-line variants with enhanced in vivo tumor growth and metastatic capacity do not express the beta 3 integrin subunit.
    Boukerche H; Benchaibi M; Berthier-Vergnes O; Lizard G; Bailly M; Bailly M; McGregor JL
    Eur J Biochem; 1994 Mar; 220(2):485-91. PubMed ID: 8125107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway.
    Rathore M; Girard C; Ohanna M; Tichet M; Ben Jouira R; Garcia E; Larbret F; Gesson M; Audebert S; Lacour JP; Montaudié H; Prod'Homme V; Tartare-Deckert S; Deckert M
    Oncogene; 2019 Jul; 38(30):5873-5889. PubMed ID: 31253871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
    Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
    Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytes facilitate melanoma brain metastasis via secretion of IL-23.
    Klein A; Schwartz H; Sagi-Assif O; Meshel T; Izraely S; Ben Menachem S; Bengaiev R; Ben-Shmuel A; Nahmias C; Couraud PO; Witz IP; Erez N
    J Pathol; 2015 May; 236(1):116-27. PubMed ID: 25639230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule).
    Degen WG; van Kempen LC; Gijzen EG; van Groningen JJ; van Kooyk Y; Bloemers HP; Swart GW
    Am J Pathol; 1998 Mar; 152(3):805-13. PubMed ID: 9502422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease.
    Thies A; Moll I; Berger J; Wagener C; Brümmer J; Schulze HJ; Brunner G; Schumacher U
    J Clin Oncol; 2002 May; 20(10):2530-6. PubMed ID: 12011132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.